These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4918160

  • 21. Relationships between antibodies and experimental allergic encephalomyelitis. II. Identification and separation of species-specific non-encephalitogenic contaminants of encephalitogenic basic proteins.
    Hruby S, Shaw CM, Alvord EC, August CS, Kies MW.
    Int Arch Allergy Appl Immunol; 1970; 37(5):532-45. PubMed ID: 5410778
    [No Abstract] [Full Text] [Related]

  • 22. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY, Fujinami RS, Day ED, Varitek VA, Pescovitz MD, Kelly J, Lorand L.
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract] [Full Text] [Related]

  • 23. Use of non-encephalitogenic fraction isolated from human brain for the detection of EAE development in guinea-pigs.
    Pekárek J, Doutlík S, Vepreková A, Jedlicka P.
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Aug; 140(2):177-83. PubMed ID: 4248066
    [No Abstract] [Full Text] [Related]

  • 24. An in vitro assay for encephalitogenic components of central nervous tissue.
    Brockman JA, Stiffey AV, Tesar WC.
    J Immunol; 1968 Jun; 100(6):1230-6. PubMed ID: 5696285
    [No Abstract] [Full Text] [Related]

  • 25. Animal models for multiple sclerosis.
    Owens T.
    Adv Neurol; 2006 Jun; 98():77-89. PubMed ID: 16400828
    [No Abstract] [Full Text] [Related]

  • 26. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA, al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL.
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [Abstract] [Full Text] [Related]

  • 27. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.
    Falk GA, Kies MW, Alvord EC.
    J Immunol; 1969 Dec; 103(6):1248-53. PubMed ID: 5361563
    [No Abstract] [Full Text] [Related]

  • 28. Further studies on the role of lipids and lipid antibodies in experimental allergic encephalomyelitis.
    Niedieck B.
    Int Arch Allergy Appl Immunol; 1969 Dec; 36():Suppl:328-33. PubMed ID: 5373031
    [No Abstract] [Full Text] [Related]

  • 29. Adjuvanticity of mycobacterial RNA and poly A:U for induction of experimental allergic encephalomyelitis in guinea pigs.
    Gumbiner C, Paterson PY, Youmans GP, Youmans AS.
    J Immunol; 1973 Jan; 110(1):309-12. PubMed ID: 4631072
    [No Abstract] [Full Text] [Related]

  • 30. Relationships between antibodies and experimental allergic encephalomyelitis. 3. Coprecipitation and radioautography of 125I-labeled antigen-antibody complexes for detection of antibodies to myelin basic protein.
    Lisak RP, Heinze RG, Kies MW.
    Int Arch Allergy Appl Immunol; 1970 Jan; 37(6):621-9. PubMed ID: 4983347
    [No Abstract] [Full Text] [Related]

  • 31. Experimental allergic encephalomyelitis: immunological properties of encephalitogenic polypeptides and proteins.
    Lamoureux G, Carnegie PR, McPherson TA, Johnston D.
    Clin Exp Immunol; 1967 Sep; 2(5):601-9. PubMed ID: 4965043
    [Abstract] [Full Text] [Related]

  • 32. [Experimental allergic encephalomyelitis--with special reference to the fluorescent antibody technic].
    Sugisaki T.
    Arerugi; 1972 Apr; 21(4):314-25. PubMed ID: 4625443
    [No Abstract] [Full Text] [Related]

  • 33. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
    Hughes RA, Leibowitz S.
    Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
    [Abstract] [Full Text] [Related]

  • 34. Complex-formation between triphosphoinositide and experimental allergic encephalitogenic protein.
    Palmer FB, Dawson RM.
    Biochem J; 1969 Mar; 111(5):637-45. PubMed ID: 4306465
    [No Abstract] [Full Text] [Related]

  • 35. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)].
    Lebar R, Voisin GA.
    Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099
    [No Abstract] [Full Text] [Related]

  • 36. [Experimental encephalomyelitis].
    Invernizzi G, Smeraldi E, Giordano F, Andreola ML.
    Folia Allergol (Roma); 1971 Nov; 18(4):296-307. PubMed ID: 4940487
    [No Abstract] [Full Text] [Related]

  • 37. Neural antigens and induction of myelination inhibition factor.
    Seil FJ, Kies MW, Bacon M.
    J Immunol; 1975 Feb; 114(2 Pt 1):630-4. PubMed ID: 47359
    [Abstract] [Full Text] [Related]

  • 38. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
    Zhitnukhin IuL, Zubzhitskiĭ IuN.
    Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
    [No Abstract] [Full Text] [Related]

  • 39. [Production of gamma globulins in the central nervous system during experimental allergic encephalomyelitis].
    Pozzuoli R, Musiani P.
    Riv Patol Nerv Ment; 1969 Jun; 90(3):197-211. PubMed ID: 4107146
    [No Abstract] [Full Text] [Related]

  • 40. Experimental allergic encephalomyelitis: serum immunoglobulin binds to myelin and oligodendrocytes in cultured tissue: ultrastructural-immunoperoxidase observations.
    Johnson AB, Raine CS, Bornstein MB.
    Lab Invest; 1979 May; 40(5):568-75. PubMed ID: 374865
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.